NCT03110601View on ClinicalTrials.gov

Study of PM Modulation Therapy in Trial Phase

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

October 12, 2017

Study Completion Date

October 12, 2017

Conditions
Chronic Pain
Interventions
DEVICE

Control - Conventional SCS

Conventional SCS Parameters

DEVICE

Test - Stimgenics SCS

Stimgenics SCS Parameters

Trial Locations (1)

61701

StimGenics, Bloomington

All Listed Sponsors
lead

Stimgenics LLC

INDUSTRY

NCT03110601 - Study of PM Modulation Therapy in Trial Phase | Biotech Hunter | Biotech Hunter